Clinical Testing Services
Trovagene offers molecular diagnostic services through its CLIA-certified, CAP-accredited laboratory. This modern facility is backed by a strong foundation in basic research into novel diagnostics and markers and has a growing list of available tests and panels.
World-Leading Research Explained
As Trovagene's common stock is listed on NASDAQ, CEO Toni Schuh explains how the company is developing novel diagnostics from analysis of cell-free nucleic acid markers found in urine.
Find out more »
Revolutionary Diagnostic Technology
Trovagene's revolutionary cell-free nucleic acid technology is enabling the development of non-invasive ways to detect, quantify and monitor genetic markers and gene mutations in urine.
What are Cell-Free Nucleic Acids?
Scientists used to think that DNA and RNA were only found within cells. With the advent of more sensitive detection equipment these nucleic acids were found in blood plasma. Trovagene scientists were the first to make the simple yet remarkable discovery that these cell-free nucleic acids filter through the kidney and appear in urine.